Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study.

White, Helen ESalmon, MatthewAlbano, FrancescoAndersen, Christina Søs AuðurBalabanov, StefanBalatzenko, GueorguiBarbany, GiselaCayuela, Jean-MichelCerveira, NunoCochaux, PascaleColomer, DolorsCoriu, DanielDiamond, JoanaDietz, ChristianDulucq, StéphanieEngvall, MarieFranke, Georg NGineikiene-Valentine, EgleGniot, MichalGómez-Casares, María TeresaGottardi, EnricoHayden, ChloeHayette, SandrineHedblom, AndreasIlea, AncaIzzo, BarbaraJiménez-Velasco, AntonioJurcek, TomasKairisto, VeliLangabeer, Stephen ELion, ThomasMeggyesi, NoraMešanović, SemirMihok, LuboslavMitterbauer-Hohendanner, GerlindeMoeckel, SylviaNaumann, NicoleNibourel, OlivierOppliger Leibundgut, ElisabethPanayiotidis, PanayiotisPodgornik, HelenaPott, ChristianeRapado, InmaculadaRose, Susan JSchäfer, VivienTouloumenidou, TasoulaVeigaard, ChristopherVenniker-Punt, BiancaVenturi, ClaudiaVigneri, PaoloVorkinn, IngvildWilkinson, ElizabethZadro, RenataZawada, MagdalenaZizkova, HanaMüller, Martin CSaussele, SusanneErnst, ThomasMachova Polakova, KaterinaHochhaus, AndreasCross, Nicholas C P2024-02-272024-02-272022-05-25http://hdl.handle.net/10668/22600http://hdl.handle.net/20.500.12105/18660Standardized monitoring of BCRengVoRhttp://creativecommons.org/licenses/by/4.0/Fatigue Syndrome, ChronicFusion Proteins, bcr-ablHumansLeukemia, Myelogenous, Chronic, BCR-ABL PositiveReference StandardsTreatment OutcomeStandardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study.Attribution 4.0 International356143193671834-184210.1038/s41375-022-01607-z1476-5551Leukemiaopen access